Rachel Smith

Rachel Smith
Executive Director
Rare Disease Center of Excellence
Parexel International

Ms. Smith brings more than a decade of experience in every development phase of rare disease and cell and gene therapy clinical trials to her work with Parexel’s rare disease clients. She has expertise in clinical development strategy, novel and adaptive trial design, decentralized trials, and other creative solutions for rare disease products with a nonclassical route to market.


Effective regulatory strategies for rare disease

August 11, 2023

In the rare disease issue of New Medicines, Novel Insights from Parexel, experts and former regulators share insights for developing effective regulatory strategies earlier.